Australia
Austria
Belgium
China
Czech Republic
Denmark
Estonia
Finland
France
Germany
Hungary
India
Ireland
Italy
Japan
Kazakhstan
Latvia
Lithuania
Malaysia
Netherlands
Norway
Poland
Singapore
Slovenia
Spain
Sweden
Switzerland
Thailand
UK
Ukraine
Investors
This section contains information about Orion as an investment.
Stock exchange releases
- 7/18/2025 Orion Group Half-Year Financial Report January–June 2025
- 7/18/2025 Orion Corporation’s financial reporting and Annual General Meeting in 2026
- 7/9/2025 Inside information: Orion upgrades full-year outlook for 2025
- 6/23/2025 141,959 Orion Corporation A shares converted into B shares
Press releases
- 7/21/2025 Darolutamide receives EU approval in third indication for patients with advanced prostate cancer
- 7/4/2025 Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025
- 6/20/2025 CHMP recommends third indication for darolutamide for patients with advanced prostate cancer
- 6/17/2025 Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
